Simultaneous acral nodular eruption and flagellate erythema caused by bleomycin.
A 29-year-old male with AIDS was treated with bleomycin and vincristine for visceral Kaposi's sarcoma. Three days later, he developed two distinct eruptions simultaneously. One eruption was characterized by tender, erythematous, edematous plaques and nodules on the palmar and dorsal surfaces of the hands, forearms, and elbows. The other consisted of grouped, erythematous, hyperpigmented streaks on the trunk, buttocks, and extremities. The patient subsequently received a second treatment consisting of vincristine with adriamycin, without bleomycin, and no cutaneous effects were seen. Diagnoses of flagellate erythema and acral nodular eruption secondary to bleomycin were made and confirmed histopathologically. To our knowledge, this is the first report of two cutaneous side effects of bleomycin appearing simultaneously in a patient with AIDS.
Mikhail
Maryann
M
The Ronald O. Perelman Department of Dermatology, New York University Medical Center, New York, NY, USA.
Eichenbaum
Mark
M
Gerstenfeld
Eric
E
Duquette
Julie
J
Pomeranz
Miriam Keltz
MK
Polsky
David
D
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D001761:Bleomycin / Q000009:adverse effects* / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D003875:Drug Eruptions / Q000473:pathology*; D004890:Erythema / Q000139:chemically induced* / Q000473:pathology*; D006801:Humans; D008297:Male; D012514:Sarcoma, Kaposi / Q000188:drug therapy; D012867:Skin / Q000473:pathology*; D014750:Vincristine / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000972:Antineoplastic Agents, Phytogenic; D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin